News1 week ago
Saar Gill, MD, PhD, as Chairman and Maksim Mamonkin, PhD, as Advisor
HOUSTON, June 6, 2023 /PRNewswire/ — NKILT Therapeutics, a new biotech company committed to the development of novel natural killer (NK) cell therapies, announced today the...
